Great Oak Capital Partners LLC Buys Shares of 6,371 Medtronic PLC $MDT

Great Oak Capital Partners LLC purchased a new position in shares of Medtronic PLC (NYSE:MDT) during the third quarter, Holdings Channel reports. The fund purchased 6,371 shares of the medical technology company’s stock, valued at approximately $604,000. Medtronic accounts for approximately 0.2% of Great Oak Capital Partners LLC’s portfolio, making the stock its 26th biggest holding.

Several other hedge funds and other institutional investors have also modified their holdings of MDT. Mayflower Financial Advisors LLC grew its stake in shares of Medtronic by 2.9% in the third quarter. Mayflower Financial Advisors LLC now owns 6,178 shares of the medical technology company’s stock valued at $588,000 after buying an additional 175 shares in the last quarter. NovaPoint Capital LLC lifted its stake in Medtronic by 13.2% during the 3rd quarter. NovaPoint Capital LLC now owns 39,840 shares of the medical technology company’s stock worth $3,794,000 after acquiring an additional 4,650 shares in the last quarter. Bard Financial Services Inc. boosted its holdings in Medtronic by 1.9% during the 3rd quarter. Bard Financial Services Inc. now owns 37,985 shares of the medical technology company’s stock valued at $3,618,000 after acquiring an additional 725 shares during the period. FSM Wealth Advisors LLC grew its position in Medtronic by 11.5% in the 3rd quarter. FSM Wealth Advisors LLC now owns 5,433 shares of the medical technology company’s stock valued at $517,000 after acquiring an additional 561 shares in the last quarter. Finally, Persium Advisors LLC grew its position in Medtronic by 6.1% in the 3rd quarter. Persium Advisors LLC now owns 8,433 shares of the medical technology company’s stock valued at $803,000 after acquiring an additional 487 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. The Goldman Sachs Group set a $111.00 price target on shares of Medtronic and gave the stock a “neutral” rating in a research report on Wednesday, November 19th. Wells Fargo & Company upped their target price on shares of Medtronic from $100.00 to $114.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 19th. Sanford C. Bernstein set a $111.00 target price on shares of Medtronic in a report on Wednesday, November 19th. Weiss Ratings restated a “buy (b)” rating on shares of Medtronic in a research note on Monday, December 15th. Finally, Leerink Partners set a $120.00 price objective on Medtronic and gave the stock an “outperform” rating in a research report on Wednesday, November 19th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $109.94.

Medtronic Trading Down 0.8%

Shares of NYSE:MDT opened at $96.52 on Friday. Medtronic PLC has a 52 week low of $79.29 and a 52 week high of $106.33. The company’s 50 day moving average is $97.54 and its two-hundred day moving average is $93.76. The company has a market cap of $123.74 billion, a PE ratio of 26.02, a P/E/G ratio of 2.54 and a beta of 0.71. The company has a current ratio of 2.42, a quick ratio of 1.80 and a debt-to-equity ratio of 0.57.

Medtronic (NYSE:MDT) last released its quarterly earnings data on Tuesday, November 18th. The medical technology company reported $1.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.05. The business had revenue of $8.96 billion during the quarter, compared to analysts’ expectations of $8.86 billion. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.26 EPS. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. Equities analysts predict that Medtronic PLC will post 5.46 earnings per share for the current fiscal year.

Medtronic Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 16th. Stockholders of record on Friday, December 26th will be issued a $0.71 dividend. The ex-dividend date is Friday, December 26th. This represents a $2.84 dividend on an annualized basis and a dividend yield of 2.9%. Medtronic’s dividend payout ratio is presently 76.55%.

Medtronic Company Profile

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).